Kymera Therapeutics Announces $250.8 Million Public Offering of Common Stock and Pre-Funded Warrants

Press/Media: Research

Period	Jun 27 2025

Media coverage

Title	Kymera Therapeutics Announces $250.8 Million Public Offering of Common Stock and Pre-Funded Warrants
Media name/outlet	Nasdaq
Country/Territory	United States
Date	6/27/25
URL	https://www.nasdaq.com/articles/kymera-therapeutics-announces-2508-million-public-offering-common-stock-and-pre-funded
Persons	Michael Schmidt